References

1.      Stern M, Williams K, Gonzalez-Villalpando C et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004;27(11):2676-81

2.      Hu G, Qiao Q, Tuomilehto J et al. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. The DECODE Insulin Study Group. Diabetologia2004;47:1245–56

3.      Carr DB, Utzschneider KM, Hull RL et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53(8):2087-94

4.      Mentes BB, Akin M, Irkörücü O, Tatlicioğlu E, Ferahköşe Z, Yildinm A, Maral I: Gastrointestinal quality of life in patients with symptomatic or asymptomatic cholelithiasis before and after laparoscopic cholecystectomy. SurgEndosc 2001, 15:1267–1272.

5.      Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (first of two parts). N Engl J Med 1978; 299:1161-7.

6.      Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med 1978; 299:1221-7.

7.      Mendez-Sanchez N, Vega H, Uribe M, et al. Risk factors for gallstone disease in Mexicans are similar to those found in Mexican-Americans. Dig Dis Sci 1998; 43:935-9.

8.      Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006; 368:230-9.

9.      Saad MF, Lillioja S, Nyomba BL et al. Racial differences in the relation between blood pressure and insulin resistance. New England Journal of Medicine 1991; 324:733-9

10.  Anderson PJ, Critchley JAJH, Chan JCN et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. International Journal of Obesity 2001;25:1782

11.  Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diabetic Medicine 1999;16:442-3

12.  Nakamura T, Tokunga K, Shimomura I et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994;107:239-46

13.  The IDF consensus worldwide definition of the Metabolic Syndrome. International Diabetic Federation,2006

14.  Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J ClinEndocrinolMetab 2008; 93(11 Suppl 1):S9-30

15.  Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 2003; 19(5):457-66. 36.

16.  Avogaro P, Crepaldi G, Enzi G, et al. Associazione di iperlipemia, diabetem-ellito e obesità di mediogrado. ActadiabetolLat1967; 4: 36-41.

17.  Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama 2002; 287: 356-359

18.  Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodríguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol2005; 11: 1653-1657

19.  Nervi F, Miquel JF, Alvarez M, Ferreccio C, García-Zattera MJ, González R, Pérez-Ayuso RM, Rigotti A, Villarroel L. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J Hepatol2006; 45: 299-305

20.  Shaffer EA. Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res ClinGastroenterol2006; 20: 981-996

21.  Acalovschi M, Buzas C, Radu C, Grigorescu M. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. J Viral Hepat2009; 16: 860-866

22.  Smelt AH. Triglycerides and gallstone formation. ClinChimActa2010; 411: 1625-1631

23.  Misra A, Wasir JS, Vikram NK. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition. 2005; 21(9):969-76.

24.  Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-52.

25.  Gaziano TA, Gaziano TM. Epidemiology of cardiovascular disease. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 18 ^th ed. New York: McGraw-Hill; 2012. p1811-6.  

26.  I-Ching Lin, Yu-Wen Yang, Mei-Feng Wu et al. The association of metabolic syndrome and its factors with gallstone disease. BMC Family Practice 2014, 15:138

27.  N Ata, M Kucukazman, B Yavuz, et al. the metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol 2010;25(5):274-276.

28.  Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez- Lara K, Ponciano-Rodríguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005; 11(11): 1653-1657

29.  Li-Ying Chen et al. Metabolic syndrome and gallstone disease. World J Gastroenterol 2012 August 21; 18(31): 4215-4220

30.  Sreenath et al. Metabolic syndrome among patients with gallstone disease - a strong risk factor for postoperative wound infection after cholecystectomy, a study from northeast India. International Journal of Current Research Vol. 6, Issue, 12, pp.11045-11050, December, 2014

31.  Chang Y, Sung E, Ryu S, Park YW, Jang YM, Park M. Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean Men. J Korean Med Sci 2008;23:644-50.

32.  Shaffer EA. Epidemiology and risk factors for gallstone disease: Has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005;7:132-40.

33.  Tazuma S. Gallstone disease: Epide-miology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol2006; 20:1075-1083

34.  Völzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005; 71: 97-105

35.  Lai SW, Muo CH, Liao KF, Sung FC, Chen PC. Risk of acute pancreatitis in type 2 diabetes and risk reduction on antidiabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol2011; 106: 1697-1704

36.  Novacek G. Gender and gallstone disease. Wien Med Wochenschr2006; 156: 527-533.

37.  Uhler ML, Marks JW, Voigt BJ, Judd HL .Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.J ClinEndocrinolMetab. 1998 Feb; 83(2):410-4

Corresponding Author

Bhan A

Final year MBBS Student, Indira Gandhi Medical College Shimla, H.P

Member of IMA-Student’s Wing Research 2015-16

Address: 2737-B, M.I.G. Super Flats, Sector-70 , Mohali, Punjab

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile: 9816816838